Publications by authors named "DS Robinson"

Claim this Profile
B
Breathing pattern disorder in chronic rhinosinusitis with severe asthma: nasal obstruction and polyps do not increase prevalence.
Rebecca Livingston, Helene Bellas, Jagdeep Sahota, Therese Bidder, Florian Vogt, Douglas S Robinson

J Asthma· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex.
Matthew C Eastwood, John Busby, David J Jackson, Ian D Pavord, Catherine E Hanratty, Douglas S Robinson

J Allergy Clin Immunol Pract· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.
P Jane McDowell, John Busby, Catherine E Hanratty, Ratko Djukanovic, Ashley Woodcock, Douglas S Robinson

Am J Respir Crit Care Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
John Busby, John G Matthews, Rekha Chaudhuri, Ian D Pavord, Timothy C Hardman, Douglas S Robinson

Eur Respir J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic characterization and thermostability of C. elegans cytoplasmic and mitochondrial malate dehydrogenases.
Matthew J Thomas, Emma R Cassidy, Devin S Robinson, Katherine M Walstrom

Biochim Biophys Acta Proteins Proteom· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of demonstration plots on improved agricultural input purchase in Tanzania: Implications for policy and practice.
Haroon Sseguya, Daniel S Robinson, Hamisi R Mwango, James A Flock, Julius Manda

PLoS One· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic rhinosinusitis with and without nasal polyps and asthma: Omalizumab improves residual anxiety but not depression.
Florian Vogt, Jagdeep Sahota, Therese Bidder, Rebecca Livingston, Helene Bellas, Douglas S Robinson

Clin Transl Allergy· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sterile Compounding Knowledge, Skills, and Confidence Among Graduating Doctor of Pharmacy Students.
Shandrika W Landry, Brittany Singleton, Sara Al-Dahir, Anh Nguyen, Donna S Robinson

Am J Pharm Educ· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Liam G Heaney, John Busby, Catherine E Hanratty, Ratko Djukanovic, Ashley Woodcock, Douglas S Robinson

Lancet Respir Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial genome editing by coupling Cre-lox and CRISPR-Cas9 systems.
Hualan Liu, David S Robinson, Zong-Yen Wu, Rita Kuo, Yasuo Yoshikuni

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Rhinosinusitis With Nasal Polyps In Patients With Aspirin Sensitivity-Mycophenolate Mofetil as an Effective Steroid-Sparing Agent.
Harsha H Kariyawasam, Maria Leandro, Magdalena Dziadzio, Douglas S Robinson, Valerie J Lund

JAMA Otolaryngol Head Neck Surg· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on new biologics for intractable eosinophilic asthma: impact of reslizumab.
Jagdeep Sahota, Douglas S Robinson

Drug Des Devel Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.
T Bidder, J Sahota, C Rennie, V J Lund, D S Robinson

Rhinology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.
Catherine E Hanratty, John G Matthews, Joseph R Arron, David F Choy, Ian D Pavord, Douglas S Robinson

Trials· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant Trials: Are the Diminishing Effect Sizes of Efficacy Trials Avoidable?
Karl Rickels, Donald S Robinson

J Clin Psychopharmacol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase three studies of biologics for severe asthma: could do better?
Douglas S Robinson, Harsha H Kariyawasam, Liam G Heaney

Eur Respir J· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting members of the BAHD acyltransferase family to synthesize multiple hydroxycinnamate and benzoate conjugates in yeast.
Aymerick Eudes, Maxence Mouille, David S Robinson, Veronica T Benites, George Wang

Microb Cell Fact· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing severe asthma.
Douglas S Robinson

Eur Respir J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mastering the prior authorization maze.
David S Robinson

MGMA Connex· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes.
Konstantinos Samitas, Nikolaos Poulos, Maria Semitekolou, Ioannis Morianos, Sofia Tousa, Douglas S Robinson

Eur Respir J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Albert Sjoerdsma.
Walter M Lovenberg, Donald S Robinson

Neuropsychopharmacology· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingerprints: A solution to protect your PHI.
David S Robinson

MGMA Connex· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab for eosinophilic severe asthma: recent studies.
Douglas S Robinson, Harsha H Kariyawasam

Expert Opin Biol Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients.
Oliver Pfaar, Angelika Sager, Douglas S Robinson

Pediatr Allergy Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3.
Zoe L Urry, David F Richards, Cheryl Black, Maria Morales, Jerónimo Carnés, Douglas S Robinson

BMC Immunol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis